Neocolipor
Neonatal piglet colibacillosis vaccine (inactivated)
Table of contents
Overview
Neocolipor is a veterinary vaccine used to reduce neonatal enterotoxicosis (a bacterial infection caused by strains of E. coli) in very young piglets.
Neocolipor contains inactivated strains of E. coli expressing the adhesins F4ab (K88ab), F4ac (K88ac), F4ad (|K88 ad) F5 (K99) F6 (987P) and F41.
Authorisation details
Product details | |
---|---|
Name |
Neocolipor
|
Agency product number |
EMEA/V/C/000035
|
Active substance |
|
International non-proprietary name (INN) or common name |
Neonatal piglet colibacillosis vaccine (inactivated)
|
Species |
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI09AB02
|
Publication details | |
---|---|
Marketing-authorisation holder |
Boehringer Ingelheim Vetmedica GmbH
|
Revision |
14
|
Date of issue of marketing authorisation valid throughout the European Union |
14/04/1998
|
Contact address |
Binger Strasse 173 |
Product information
15/05/2020 Neocolipor - EMEA/V/C/000035 - IG/1242/0014
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
-
Immunologicals for suidae
-
Inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia)
Therapeutic indication
Reduction of neonatal enterotoxicosis of piglets, caused by E. coli strains, expressing the adhesins F4ab, F4ac, F4ad, F5, F6 and F41, during the first days of life.